AbbVie Strikes Again By Teeing Up $8.7bn Offer For Cerevel

 
• By Joseph Haas
Big deal
AbbVie will pay $8.7bn for Cerevel to boost its neurology portfolio • Source: Shutterstock

More from Deals

More from Business